• Folder
  • Folder
  • Search
    Close
Close
Close
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Close

Latest News

Recent Publications

Upcoming Events

Recent Videos

Reimbursement

  • Print
  • Email

Practice Leaders

関連分野

Alston & Bird counsels drug and device manufacturers, health care providers and suppliers on a variety of matters along the Medicare and Medicaid reimbursement continuum, including coverage, coding and payment issues. We work closely with the executive branch—including the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA)—and Congress to help our clients achieve innovative solutions to their reimbursement issues.

Specifically, we help our clients develop comprehensive reimbursement strategies for new and established therapies, technologies and services. We assist companies in obtaining favorable coverage policies (i.e., local and national Medicare coverage and utilization decisions) and appropriate payment for their services and products. Because of our experienced team, we are able to develop a regulatory and legislative strategy that combines scientific data, legal analysis, and legislative advocacy at all levels of government. We also help clients manage regulatory processes governing waivers and Medicaid managed-care programs, Medicaid drug rebate programs, and provider survey and certification requirements. We also work in collaboration with our health care litigation practice to assist in defending clients who are challenged by federal or state enforcement agencies.